Global Diagnostic Nuclear Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
LPI (LP Information)' newest research report, the “Diagnostic Nuclear Drug Industry Forecast” looks at past sales and reviews total world Diagnostic Nuclear Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostic Nuclear Drug sales for 2023 through 2029. With Diagnostic Nuclear Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Nuclear Drug industry.
This Insight Report provides a comprehensive analysis of the global Diagnostic Nuclear Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Nuclear Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostic Nuclear Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Nuclear Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Nuclear Drug.
The global Diagnostic Nuclear Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Diagnostic Nuclear Drug players cover Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes, Lantheus, GE Healthcare, China Isotope & Radiation and Jubilant Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
LPI (LP Information)' newest research report, the “Diagnostic Nuclear Drug Industry Forecast” looks at past sales and reviews total world Diagnostic Nuclear Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostic Nuclear Drug sales for 2023 through 2029. With Diagnostic Nuclear Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Nuclear Drug industry.
This Insight Report provides a comprehensive analysis of the global Diagnostic Nuclear Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Nuclear Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostic Nuclear Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Nuclear Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Nuclear Drug.
The global Diagnostic Nuclear Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Diagnostic Nuclear Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Diagnostic Nuclear Drug players cover Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes, Lantheus, GE Healthcare, China Isotope & Radiation and Jubilant Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Tc-99m
- F-18
- Other
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco Imaging
- Bayer
- Curium Pharmaceuticals
- Nordion
- Triad Isotopes
- Lantheus
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Novartis
- SIEMENS
- Dongcheng
- Navidea
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size 2018-2029
2.1.2 Diagnostic Nuclear Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Diagnostic Nuclear Drug Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Drug Market Size by Type
2.3.1 Diagnostic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
2.4 Diagnostic Nuclear Drug Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Drug Market Size by Application
2.5.1 Diagnostic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
3 DIAGNOSTIC NUCLEAR DRUG MARKET SIZE BY PLAYER
3.1 Diagnostic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Diagnostic Nuclear Drug Revenue by Players (2018-2023)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Diagnostic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC NUCLEAR DRUG BY REGIONS
4.1 Diagnostic Nuclear Drug Market Size by Regions (2018-2023)
4.2 Americas Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.3 APAC Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.4 Europe Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Diagnostic Nuclear Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Diagnostic Nuclear Drug Market Size by Country (2018-2023)
5.2 Americas Diagnostic Nuclear Drug Market Size by Type (2018-2023)
5.3 Americas Diagnostic Nuclear Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Nuclear Drug Market Size by Region (2018-2023)
6.2 APAC Diagnostic Nuclear Drug Market Size by Type (2018-2023)
6.3 APAC Diagnostic Nuclear Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diagnostic Nuclear Drug by Country (2018-2023)
7.2 Europe Diagnostic Nuclear Drug Market Size by Type (2018-2023)
7.3 Europe Diagnostic Nuclear Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Nuclear Drug by Region (2018-2023)
8.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIAGNOSTIC NUCLEAR DRUG MARKET FORECAST
10.1 Global Diagnostic Nuclear Drug Forecast by Regions (2024-2029)
10.1.1 Global Diagnostic Nuclear Drug Forecast by Regions (2024-2029)
10.1.2 Americas Diagnostic Nuclear Drug Forecast
10.1.3 APAC Diagnostic Nuclear Drug Forecast
10.1.4 Europe Diagnostic Nuclear Drug Forecast
10.1.5 Middle East & Africa Diagnostic Nuclear Drug Forecast
10.2 Americas Diagnostic Nuclear Drug Forecast by Country (2024-2029)
10.2.1 United States Diagnostic Nuclear Drug Market Forecast
10.2.2 Canada Diagnostic Nuclear Drug Market Forecast
10.2.3 Mexico Diagnostic Nuclear Drug Market Forecast
10.2.4 Brazil Diagnostic Nuclear Drug Market Forecast
10.3 APAC Diagnostic Nuclear Drug Forecast by Region (2024-2029)
10.3.1 China Diagnostic Nuclear Drug Market Forecast
10.3.2 Japan Diagnostic Nuclear Drug Market Forecast
10.3.3 Korea Diagnostic Nuclear Drug Market Forecast
10.3.4 Southeast Asia Diagnostic Nuclear Drug Market Forecast
10.3.5 India Diagnostic Nuclear Drug Market Forecast
10.3.6 Australia Diagnostic Nuclear Drug Market Forecast
10.4 Europe Diagnostic Nuclear Drug Forecast by Country (2024-2029)
10.4.1 Germany Diagnostic Nuclear Drug Market Forecast
10.4.2 France Diagnostic Nuclear Drug Market Forecast
10.4.3 UK Diagnostic Nuclear Drug Market Forecast
10.4.4 Italy Diagnostic Nuclear Drug Market Forecast
10.4.5 Russia Diagnostic Nuclear Drug Market Forecast
10.5 Middle East & Africa Diagnostic Nuclear Drug Forecast by Region (2024-2029)
10.5.1 Egypt Diagnostic Nuclear Drug Market Forecast
10.5.2 South Africa Diagnostic Nuclear Drug Market Forecast
10.5.3 Israel Diagnostic Nuclear Drug Market Forecast
10.5.4 Turkey Diagnostic Nuclear Drug Market Forecast
10.5.5 GCC Countries Diagnostic Nuclear Drug Market Forecast
10.6 Global Diagnostic Nuclear Drug Forecast by Type (2024-2029)
10.7 Global Diagnostic Nuclear Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Diagnostic Nuclear Drug Product Offered
11.1.3 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bracco Imaging Main Business Overview
11.1.5 Bracco Imaging Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Diagnostic Nuclear Drug Product Offered
11.2.3 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Company Information
11.3.2 Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharmaceuticals Main Business Overview
11.3.5 Curium Pharmaceuticals Latest Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Diagnostic Nuclear Drug Product Offered
11.4.3 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nordion Main Business Overview
11.4.5 Nordion Latest Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Diagnostic Nuclear Drug Product Offered
11.5.3 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Triad Isotopes Main Business Overview
11.5.5 Triad Isotopes Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Diagnostic Nuclear Drug Product Offered
11.6.3 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Diagnostic Nuclear Drug Product Offered
11.7.3 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Information
11.8.2 China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 China Isotope & Radiation Main Business Overview
11.8.5 China Isotope & Radiation Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Diagnostic Nuclear Drug Product Offered
11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Diagnostic Nuclear Drug Product Offered
11.10.3 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Diagnostic Nuclear Drug Product Offered
11.11.3 Novartis Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 SIEMENS
11.12.1 SIEMENS Company Information
11.12.2 SIEMENS Diagnostic Nuclear Drug Product Offered
11.12.3 SIEMENS Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 SIEMENS Main Business Overview
11.12.5 SIEMENS Latest Developments
11.13 Dongcheng
11.13.1 Dongcheng Company Information
11.13.2 Dongcheng Diagnostic Nuclear Drug Product Offered
11.13.3 Dongcheng Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Dongcheng Main Business Overview
11.13.5 Dongcheng Latest Developments
11.14 Navidea
11.14.1 Navidea Company Information
11.14.2 Navidea Diagnostic Nuclear Drug Product Offered
11.14.3 Navidea Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Navidea Main Business Overview
11.14.5 Navidea Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Drug Market Size 2018-2029
2.1.2 Diagnostic Nuclear Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Diagnostic Nuclear Drug Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Drug Market Size by Type
2.3.1 Diagnostic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
2.4 Diagnostic Nuclear Drug Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Drug Market Size by Application
2.5.1 Diagnostic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
3 DIAGNOSTIC NUCLEAR DRUG MARKET SIZE BY PLAYER
3.1 Diagnostic Nuclear Drug Market Size Market Share by Players
3.1.1 Global Diagnostic Nuclear Drug Revenue by Players (2018-2023)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2023)
3.2 Global Diagnostic Nuclear Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC NUCLEAR DRUG BY REGIONS
4.1 Diagnostic Nuclear Drug Market Size by Regions (2018-2023)
4.2 Americas Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.3 APAC Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.4 Europe Diagnostic Nuclear Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Diagnostic Nuclear Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Diagnostic Nuclear Drug Market Size by Country (2018-2023)
5.2 Americas Diagnostic Nuclear Drug Market Size by Type (2018-2023)
5.3 Americas Diagnostic Nuclear Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diagnostic Nuclear Drug Market Size by Region (2018-2023)
6.2 APAC Diagnostic Nuclear Drug Market Size by Type (2018-2023)
6.3 APAC Diagnostic Nuclear Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diagnostic Nuclear Drug by Country (2018-2023)
7.2 Europe Diagnostic Nuclear Drug Market Size by Type (2018-2023)
7.3 Europe Diagnostic Nuclear Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diagnostic Nuclear Drug by Region (2018-2023)
8.2 Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIAGNOSTIC NUCLEAR DRUG MARKET FORECAST
10.1 Global Diagnostic Nuclear Drug Forecast by Regions (2024-2029)
10.1.1 Global Diagnostic Nuclear Drug Forecast by Regions (2024-2029)
10.1.2 Americas Diagnostic Nuclear Drug Forecast
10.1.3 APAC Diagnostic Nuclear Drug Forecast
10.1.4 Europe Diagnostic Nuclear Drug Forecast
10.1.5 Middle East & Africa Diagnostic Nuclear Drug Forecast
10.2 Americas Diagnostic Nuclear Drug Forecast by Country (2024-2029)
10.2.1 United States Diagnostic Nuclear Drug Market Forecast
10.2.2 Canada Diagnostic Nuclear Drug Market Forecast
10.2.3 Mexico Diagnostic Nuclear Drug Market Forecast
10.2.4 Brazil Diagnostic Nuclear Drug Market Forecast
10.3 APAC Diagnostic Nuclear Drug Forecast by Region (2024-2029)
10.3.1 China Diagnostic Nuclear Drug Market Forecast
10.3.2 Japan Diagnostic Nuclear Drug Market Forecast
10.3.3 Korea Diagnostic Nuclear Drug Market Forecast
10.3.4 Southeast Asia Diagnostic Nuclear Drug Market Forecast
10.3.5 India Diagnostic Nuclear Drug Market Forecast
10.3.6 Australia Diagnostic Nuclear Drug Market Forecast
10.4 Europe Diagnostic Nuclear Drug Forecast by Country (2024-2029)
10.4.1 Germany Diagnostic Nuclear Drug Market Forecast
10.4.2 France Diagnostic Nuclear Drug Market Forecast
10.4.3 UK Diagnostic Nuclear Drug Market Forecast
10.4.4 Italy Diagnostic Nuclear Drug Market Forecast
10.4.5 Russia Diagnostic Nuclear Drug Market Forecast
10.5 Middle East & Africa Diagnostic Nuclear Drug Forecast by Region (2024-2029)
10.5.1 Egypt Diagnostic Nuclear Drug Market Forecast
10.5.2 South Africa Diagnostic Nuclear Drug Market Forecast
10.5.3 Israel Diagnostic Nuclear Drug Market Forecast
10.5.4 Turkey Diagnostic Nuclear Drug Market Forecast
10.5.5 GCC Countries Diagnostic Nuclear Drug Market Forecast
10.6 Global Diagnostic Nuclear Drug Forecast by Type (2024-2029)
10.7 Global Diagnostic Nuclear Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Information
11.1.2 Bracco Imaging Diagnostic Nuclear Drug Product Offered
11.1.3 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bracco Imaging Main Business Overview
11.1.5 Bracco Imaging Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Diagnostic Nuclear Drug Product Offered
11.2.3 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Curium Pharmaceuticals
11.3.1 Curium Pharmaceuticals Company Information
11.3.2 Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
11.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Curium Pharmaceuticals Main Business Overview
11.3.5 Curium Pharmaceuticals Latest Developments
11.4 Nordion
11.4.1 Nordion Company Information
11.4.2 Nordion Diagnostic Nuclear Drug Product Offered
11.4.3 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Nordion Main Business Overview
11.4.5 Nordion Latest Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Information
11.5.2 Triad Isotopes Diagnostic Nuclear Drug Product Offered
11.5.3 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Triad Isotopes Main Business Overview
11.5.5 Triad Isotopes Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Diagnostic Nuclear Drug Product Offered
11.6.3 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Diagnostic Nuclear Drug Product Offered
11.7.3 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Information
11.8.2 China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 China Isotope & Radiation Main Business Overview
11.8.5 China Isotope & Radiation Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Diagnostic Nuclear Drug Product Offered
11.9.3 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Diagnostic Nuclear Drug Product Offered
11.10.3 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Diagnostic Nuclear Drug Product Offered
11.11.3 Novartis Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 SIEMENS
11.12.1 SIEMENS Company Information
11.12.2 SIEMENS Diagnostic Nuclear Drug Product Offered
11.12.3 SIEMENS Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 SIEMENS Main Business Overview
11.12.5 SIEMENS Latest Developments
11.13 Dongcheng
11.13.1 Dongcheng Company Information
11.13.2 Dongcheng Diagnostic Nuclear Drug Product Offered
11.13.3 Dongcheng Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Dongcheng Main Business Overview
11.13.5 Dongcheng Latest Developments
11.14 Navidea
11.14.1 Navidea Company Information
11.14.2 Navidea Diagnostic Nuclear Drug Product Offered
11.14.3 Navidea Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Navidea Main Business Overview
11.14.5 Navidea Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Diagnostic Nuclear Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tc-99m
Table 3. Major Players of F-18
Table 4. Major Players of Other
Table 5. Diagnostic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 8. Diagnostic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Diagnostic Nuclear Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Diagnostic Nuclear Drug Revenue Market Share by Player (2018-2023)
Table 13. Diagnostic Nuclear Drug Key Players Head office and Products Offered
Table 14. Diagnostic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diagnostic Nuclear Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Diagnostic Nuclear Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Diagnostic Nuclear Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Diagnostic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Diagnostic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Diagnostic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Diagnostic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Diagnostic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Diagnostic Nuclear Drug
Table 46. Key Market Challenges & Risks of Diagnostic Nuclear Drug
Table 47. Key Industry Trends of Diagnostic Nuclear Drug
Table 48. Global Diagnostic Nuclear Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Diagnostic Nuclear Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Diagnostic Nuclear Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bracco Imaging Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 53. Bracco Imaging Diagnostic Nuclear Drug Product Offered
Table 54. Bracco Imaging Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bracco Imaging Main Business
Table 56. Bracco Imaging Latest Developments
Table 57. Bayer Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 58. Bayer Diagnostic Nuclear Drug Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bayer Latest Developments
Table 62. Curium Pharmaceuticals Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 63. Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
Table 64. Curium Pharmaceuticals Main Business
Table 65. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Curium Pharmaceuticals Latest Developments
Table 67. Nordion Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 68. Nordion Diagnostic Nuclear Drug Product Offered
Table 69. Nordion Main Business
Table 70. Nordion Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Nordion Latest Developments
Table 72. Triad Isotopes Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 73. Triad Isotopes Diagnostic Nuclear Drug Product Offered
Table 74. Triad Isotopes Main Business
Table 75. Triad Isotopes Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Triad Isotopes Latest Developments
Table 77. Lantheus Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 78. Lantheus Diagnostic Nuclear Drug Product Offered
Table 79. Lantheus Main Business
Table 80. Lantheus Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Lantheus Latest Developments
Table 82. GE Healthcare Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 83. GE Healthcare Diagnostic Nuclear Drug Product Offered
Table 84. GE Healthcare Main Business
Table 85. GE Healthcare Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. GE Healthcare Latest Developments
Table 87. China Isotope & Radiation Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 88. China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
Table 89. China Isotope & Radiation Main Business
Table 90. China Isotope & Radiation Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. China Isotope & Radiation Latest Developments
Table 92. Jubilant Pharma Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 93. Jubilant Pharma Diagnostic Nuclear Drug Product Offered
Table 94. Jubilant Pharma Main Business
Table 95. Jubilant Pharma Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Jubilant Pharma Latest Developments
Table 97. Eli Lilly Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 98. Eli Lilly Diagnostic Nuclear Drug Product Offered
Table 99. Eli Lilly Main Business
Table 100. Eli Lilly Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Eli Lilly Latest Developments
Table 102. Novartis Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 103. Novartis Diagnostic Nuclear Drug Product Offered
Table 104. Novartis Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. SIEMENS Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 108. SIEMENS Diagnostic Nuclear Drug Product Offered
Table 109. SIEMENS Main Business
Table 110. SIEMENS Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. SIEMENS Latest Developments
Table 112. Dongcheng Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 113. Dongcheng Diagnostic Nuclear Drug Product Offered
Table 114. Dongcheng Main Business
Table 115. Dongcheng Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Dongcheng Latest Developments
Table 117. Navidea Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 118. Navidea Diagnostic Nuclear Drug Product Offered
Table 119. Navidea Main Business
Table 120. Navidea Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Navidea Latest Developments
Table 1. Diagnostic Nuclear Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Tc-99m
Table 3. Major Players of F-18
Table 4. Major Players of Other
Table 5. Diagnostic Nuclear Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 8. Diagnostic Nuclear Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Diagnostic Nuclear Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Diagnostic Nuclear Drug Revenue Market Share by Player (2018-2023)
Table 13. Diagnostic Nuclear Drug Key Players Head office and Products Offered
Table 14. Diagnostic Nuclear Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diagnostic Nuclear Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Diagnostic Nuclear Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Diagnostic Nuclear Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Diagnostic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Diagnostic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Diagnostic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Diagnostic Nuclear Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Diagnostic Nuclear Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Diagnostic Nuclear Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Diagnostic Nuclear Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Diagnostic Nuclear Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Diagnostic Nuclear Drug
Table 46. Key Market Challenges & Risks of Diagnostic Nuclear Drug
Table 47. Key Industry Trends of Diagnostic Nuclear Drug
Table 48. Global Diagnostic Nuclear Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Diagnostic Nuclear Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Diagnostic Nuclear Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bracco Imaging Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 53. Bracco Imaging Diagnostic Nuclear Drug Product Offered
Table 54. Bracco Imaging Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bracco Imaging Main Business
Table 56. Bracco Imaging Latest Developments
Table 57. Bayer Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 58. Bayer Diagnostic Nuclear Drug Product Offered
Table 59. Bayer Main Business
Table 60. Bayer Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bayer Latest Developments
Table 62. Curium Pharmaceuticals Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 63. Curium Pharmaceuticals Diagnostic Nuclear Drug Product Offered
Table 64. Curium Pharmaceuticals Main Business
Table 65. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Curium Pharmaceuticals Latest Developments
Table 67. Nordion Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 68. Nordion Diagnostic Nuclear Drug Product Offered
Table 69. Nordion Main Business
Table 70. Nordion Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Nordion Latest Developments
Table 72. Triad Isotopes Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 73. Triad Isotopes Diagnostic Nuclear Drug Product Offered
Table 74. Triad Isotopes Main Business
Table 75. Triad Isotopes Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Triad Isotopes Latest Developments
Table 77. Lantheus Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 78. Lantheus Diagnostic Nuclear Drug Product Offered
Table 79. Lantheus Main Business
Table 80. Lantheus Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Lantheus Latest Developments
Table 82. GE Healthcare Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 83. GE Healthcare Diagnostic Nuclear Drug Product Offered
Table 84. GE Healthcare Main Business
Table 85. GE Healthcare Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. GE Healthcare Latest Developments
Table 87. China Isotope & Radiation Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 88. China Isotope & Radiation Diagnostic Nuclear Drug Product Offered
Table 89. China Isotope & Radiation Main Business
Table 90. China Isotope & Radiation Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. China Isotope & Radiation Latest Developments
Table 92. Jubilant Pharma Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 93. Jubilant Pharma Diagnostic Nuclear Drug Product Offered
Table 94. Jubilant Pharma Main Business
Table 95. Jubilant Pharma Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Jubilant Pharma Latest Developments
Table 97. Eli Lilly Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 98. Eli Lilly Diagnostic Nuclear Drug Product Offered
Table 99. Eli Lilly Main Business
Table 100. Eli Lilly Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Eli Lilly Latest Developments
Table 102. Novartis Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 103. Novartis Diagnostic Nuclear Drug Product Offered
Table 104. Novartis Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. SIEMENS Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 108. SIEMENS Diagnostic Nuclear Drug Product Offered
Table 109. SIEMENS Main Business
Table 110. SIEMENS Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. SIEMENS Latest Developments
Table 112. Dongcheng Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 113. Dongcheng Diagnostic Nuclear Drug Product Offered
Table 114. Dongcheng Main Business
Table 115. Dongcheng Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Dongcheng Latest Developments
Table 117. Navidea Details, Company Type, Diagnostic Nuclear Drug Area Served and Its Competitors
Table 118. Navidea Diagnostic Nuclear Drug Product Offered
Table 119. Navidea Main Business
Table 120. Navidea Diagnostic Nuclear Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Navidea Latest Developments
LIST OF FIGURES
Figure 1. Diagnostic Nuclear Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diagnostic Nuclear Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Diagnostic Nuclear Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Diagnostic Nuclear Drug Sales Market Share by Country/Region (2022)
Figure 8. Diagnostic Nuclear Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Diagnostic Nuclear Drug Market Size Market Share by Type in 2022
Figure 10. Diagnostic Nuclear Drug in Oncology
Figure 11. Global Diagnostic Nuclear Drug Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Diagnostic Nuclear Drug in Cardiology
Figure 13. Global Diagnostic Nuclear Drug Market: Cardiology (2018-2023) & ($ Millions)
Figure 14. Diagnostic Nuclear Drug in Other
Figure 15. Global Diagnostic Nuclear Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Diagnostic Nuclear Drug Market Size Market Share by Application in 2022
Figure 17. Global Diagnostic Nuclear Drug Revenue Market Share by Player in 2022
Figure 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Diagnostic Nuclear Drug Value Market Share by Country in 2022
Figure 24. United States Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Region in 2022
Figure 29. APAC Diagnostic Nuclear Drug Market Size Market Share by Type in 2022
Figure 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Application in 2022
Figure 31. China Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Diagnostic Nuclear Drug Market Size Market Share by Country in 2022
Figure 38. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Diagnostic Nuclear Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diagnostic Nuclear Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Diagnostic Nuclear Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Diagnostic Nuclear Drug Sales Market Share by Country/Region (2022)
Figure 8. Diagnostic Nuclear Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Diagnostic Nuclear Drug Market Size Market Share by Type in 2022
Figure 10. Diagnostic Nuclear Drug in Oncology
Figure 11. Global Diagnostic Nuclear Drug Market: Oncology (2018-2023) & ($ Millions)
Figure 12. Diagnostic Nuclear Drug in Cardiology
Figure 13. Global Diagnostic Nuclear Drug Market: Cardiology (2018-2023) & ($ Millions)
Figure 14. Diagnostic Nuclear Drug in Other
Figure 15. Global Diagnostic Nuclear Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Diagnostic Nuclear Drug Market Size Market Share by Application in 2022
Figure 17. Global Diagnostic Nuclear Drug Revenue Market Share by Player in 2022
Figure 18. Global Diagnostic Nuclear Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Diagnostic Nuclear Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Diagnostic Nuclear Drug Value Market Share by Country in 2022
Figure 24. United States Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Diagnostic Nuclear Drug Market Size Market Share by Region in 2022
Figure 29. APAC Diagnostic Nuclear Drug Market Size Market Share by Type in 2022
Figure 30. APAC Diagnostic Nuclear Drug Market Size Market Share by Application in 2022
Figure 31. China Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Diagnostic Nuclear Drug Market Size Market Share by Country in 2022
Figure 38. Europe Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Diagnostic Nuclear Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Diagnostic Nuclear Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Diagnostic Nuclear Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Diagnostic Nuclear Drug Market Size Market Share Forecast by Application (2024-2029)
